Related Experiment Video
Updated: Mar 1, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Cervical Cancer Screening
George F Sawaya1, Megan J Huchko2
1Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, 550 16th Street, Floor 7, San Francisco, CA 94143, USA; Department of Epidemiology & Biostatistics, University of California, San Francisco, 550 16th Street, Floor 7, San Francisco, CA 94143, USA.
Abstract:
Cervical cancer screening in the United States has accompanied profound decreases in cancer incidence and mortality over the last half century. Two screening strategies are currently endorsed by US-based guideline groups: (1) triennial cytology for women aged 21 to 65 years, and (2) triennial cytology for women aged 21 to 29 years followed by cytology plus testing for high-risk human papillomavirus types every 5 years for women aged 30 years and older. Providing women with affordable, easily accessible screening, follow-up of abnormal tests, and timely treatment will result in the greatest impact of screening on cervical cancer incidence and mortality.
More Related Videos
Related Concept Videos
Preventive Healthcare Services
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Uterus and Cervix
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...

